MedPath

华润紫竹药业有限公司

Ownership
-
Established
1980-11-26
Employees
-
Market Cap
-
Website
https://www.zizhu-pharm.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

297

NMPA:297

Drug Approvals

Compound Levonorgestrel Tablets

Product Name
复方左炔诺孕酮片
Approval Number
国药准字H11020047
Approval Date
Oct 22, 2024
NMPA

Aminophylline Tablets

Product Name
氨茶碱片
Approval Number
国药准字H11020445
Approval Date
Oct 22, 2024
NMPA

Complex Patching Paracetamol and Chlorphenamine Maleate Tablets and Vitamin B1 and Chlorphenamine Maleate Tablets

Product Name
氨酚那敏片、维B1那敏片复合包装
Approval Number
国药准字H11022170
Approval Date
Oct 22, 2024
NMPA

Levonorgestrel and Quinestrol Tablets

Product Name
左炔诺孕酮炔雌醚片
Approval Number
国药准字H11021378
Approval Date
Jul 22, 2024
NMPA

Gestrinone Capsules

Product Name
言昌
Approval Number
国药准字H19980020
Approval Date
Jul 22, 2024
NMPA

Levonorgestrel Tablets

Product Name
毓婷
Approval Number
国药准字H11021372
Approval Date
Jul 22, 2024
NMPA

Tibolone Tablets

Product Name
紫竹爱维
Approval Number
国药准字H20020198
Approval Date
Jul 22, 2024
NMPA

Levonorgestrel Tablets

Product Name
毓婷
Approval Number
国药准字H10983129
Approval Date
Jul 22, 2024
NMPA

Epalrestat Tablets

Product Name
依帕司他片
Approval Number
国药准字H20143229
Approval Date
Apr 16, 2024
NMPA

Diquafosol Sodium Eye Drops

Product Name
地夸磷索钠滴眼液
Approval Number
国药准字H20243438
Approval Date
Apr 7, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 30
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.